Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ezetimibe lipid loWering Trial On PreventIon of Atherosclerosis in 75 or older

Trial Profile

Ezetimibe lipid loWering Trial On PreventIon of Atherosclerosis in 75 or older

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 16 Oct 2018

At a glance

  • Drugs Ezetimibe (Primary)
  • Indications Cardiovascular disorders; Hypercholesterolaemia; Myocardial infarction; Stroke
  • Focus Therapeutic Use
  • Acronyms EWTOPIA75
  • Most Recent Events

    • 27 Apr 2016 Status changed from active, no longer recruiting to discontinued.
    • 24 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top